article thumbnail

The Composition and Value of a Portfolio Analysis

Camargo

Clinical pharmacology may also involve comparative bioavailability analyses, which are generally required for drug formulation bridging studies, to demonstrate bioequivalence. Scientist, Regulatory Strategy. Biowaiver Eligibility. Nonclinical Requirements. Chemistry, Manufacturing, and Controls (CMC) Strategies.